WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹15 Cr | ₹-32 Cr | ₹-29 Cr | ₹-17 Cr | ₹-108 Cr |
What is the latest Cash Flow from Financing Activities ratio of WANBURY ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹15 Cr |
Mar2023 | ₹-32 Cr |
Mar2022 | ₹-29 Cr |
Mar2021 | ₹-17 Cr |
Mar2020 | ₹-108 Cr |
How is Cash Flow from Financing Activities of WANBURY Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹15 Cr | Positive | |
Mar2023 | ₹-32 Cr | Negative | |
Mar2022 | ₹-29 Cr | Negative | |
Mar2021 | ₹-17 Cr | Negative | |
Mar2020 | ₹-108 Cr | - |
Compare Cash Flow from Financing Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹790.0 Cr | -2.1% | -13.2% | 66% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,400.0 Cr | 2% | -0.9% | 31.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,622.0 Cr | -1.6% | -0.4% | 57.3% | Stock Analytics | |
CIPLA | ₹116,240.0 Cr | -0.3% | -2.5% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,166.0 Cr | -0.5% | -3.3% | 14% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,495.2 Cr | -1% | 0.6% | 39.1% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -2.1% |
-13.2% |
66% |
SENSEX | -0.4% |
-2.1% |
6.9% |
You may also like the below Video Courses